Despite higher TTVL, ATG recipients did not show an increased risk of hospitalization for infections compared to IL-2 RA recipients, suggesting that a higher TTVL in ATG recipients does not necessarily translate into clinical complications. This evidence concerns the gene IL2 and rheumatoid arthritis.